WISDOM trial weighs risk-based cancer screening

University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based breast cancer screening and annual mammography. Rates of stage ≥IIB breast cancers met a noninferiority threshold under risk-based screening, and breast biopsy rates ran higher rather than lower.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup